Complete Filing Data
IOVANCE BIOTHERAPEUTICS, INC. reported Net Income Loss of -$390.98 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean IOVANCE BIOTHERAPEUTICS, INC. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$391.0M | -$372.2M | -$444.0M | -$395.9M | -$342.3M | -$259.6M | -$197.6M | -$123.6M | -$92.1M | -$52.9M | -$27.7M | -$12.0M | -$25.4M | -$3.3M | -$25.7M | -$1.6M | -$15.8K | -$58.7K |
| Revenue * | $263.5M | $164.1M | $1.2M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Operating Income Loss | -$403.4M | -$395.3M | -$460.6M | -$398.9M | -$342.7M | -$261.9M | -$206.9M | -$128.3M | -$92.9M | -$53.6M | -$27.9M | -$12.0M | -$22.6M | -$8.1M | -$21.2M | -$815.4K | -$15.8K | |
| Research And Development Expense | $300.3M | $276.2M | $333.2M | $294.8M | $259.0M | $201.7M | $166.0M | $99.8M | $71.6M | $26.9M | $15.5M | $3.8M | $2.2M | $1.7M | $1.8M | $171.5K | $0.00 | |
| Operating Expenses | $398.9M | $342.7M | $261.9M | $206.9M | $128.3M | $92.9M | $53.6M | $27.9M | $12.0M | $22.6M | $8.1M | $21.2M | $815.4K | $15.8K | ||||
| Comprehensive Income Net Of Tax | -$373.5M | -$375.7M | -$440.6M | -$396.2M | -$342.9M | -$259.8M | -$197.3M | -$123.6M | -$92.1M | -$52.9M | -$27.6M | -$12.0M | -$25.4M | |||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$54.0K | $78.0K | $940.0K | -$301.0K | -$620.0K | -$201.0K | $262.0K | -$42.0K | -$29.0K | -$19.0K | $48.0K | $0.00 | $0.00 | |||||
| General And Administrative Expense | $152.3M | $152.3M | $106.1M | $104.1M | $83.7M | $60.2M | $40.8M | $28.4M | $21.3M | $26.7M | $12.4M | $8.2M | $3.8M | |||||
| Other Nonoperating Income Expense | $200.0K | $6.0K | -$2.7M | $4.8M | -$4.5M | -$792.6K | $0.00 | |||||||||||
| Interest Expense | -$5.7K | $444.7K | $1.9M | $151.5K | $0.00 | $0.00 | ||||||||||||
| Impairment Of Intangible Assets Excluding Goodwill | $0.00 | $0.00 | $160.0K | $0.00 | $0.00 | |||||||||||||
| Cost Of Revenue | $173.2M | $93.2M | $1.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q1 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$91.3M | -$111.7M | -$116.2M | -$83.5M | -$97.1M | -$113.0M | -$113.8M | -$106.5M | -$107.4M | -$99.6M | -$99.3M | -$91.6M | -$86.1M | -$81.4M | -$75.4M | -$68.4M | -$58.6M | -$63.0M | -$69.6M | -$63.6M | -$49.5M | -$47.6M | -$37.0M | -$32.6M | -$33.8M | -$30.7M | -$26.5M | -$25.9M | -$22.1M | -$23.4M | -$20.7M | -$15.7M | -$68.2M | -$11.6M | -$6.9M | -$8.4M | -$7.6M | -$6.4M | -$5.3M | -$4.7M | -$3.0M | -$2.1M | -$2.3M | -$9.4M | -$3.4M | -$1.0M | -$673.9K | -$327.3K | -$5.8M | -$5.8M | -$564.3K |
| Revenue * | $67.5M | $60.0M | $49.3M | $58.6M | $31.1M | $715.0K | $469.0K | $238.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||
| Operating Income Loss | -$94.9M | -$113.8M | -$121.2M | -$89.1M | -$101.9M | -$117.7M | -$118.4M | -$110.1M | -$110.9M | -$100.4M | -$99.7M | -$91.7M | -$86.2M | -$81.4M | -$75.6M | -$59.0M | -$63.6M | -$70.8M | -$51.6M | -$50.2M | -$40.0M | -$35.1M | -$31.4M | -$26.9M | -$22.3M | -$23.6M | -$20.9M | -$19.0M | -$11.7M | -$7.0M | -$7.6M | -$6.4M | -$5.3M | -$2.8M | -$2.1M | -$2.3M | -$9.4M | -$1.0M | -$704.9K | -$1.6M | -$1.6M | -$3.1M | -$5.8M | -$658.3K | |||||||
| Research And Development Expense | $75.2M | $79.4M | $76.9M | $67.0M | $62.1M | $79.8M | $87.5M | $86.3M | $82.7M | $72.5M | $73.4M | $68.3M | $65.4M | $62.1M | $55.9M | $43.1M | $49.3M | $57.0M | $41.6M | $39.3M | $30.9M | $27.9M | $24.6M | $19.9M | $16.7M | $18.6M | $15.6M | $8.5M | $4.5M | $4.2M | $5.0M | $4.1M | $2.4M | $354.0K | $494.0K | $302.7K | $250.0K | $250.0K | $270.0K | $250.0K | $270.0K | $886.0K | $0.00 | $0.00 | |||||||
| Operating Expenses | $110.9M | $100.4M | $99.7M | $91.7M | $86.2M | $81.4M | $75.6M | $59.0M | $63.6M | $70.8M | $51.6M | $50.2M | $40.0M | $35.1M | $31.4M | $26.9M | $22.3M | $23.6M | $20.9M | $19.0M | $11.7M | $7.0M | $7.6M | $6.4M | $5.3M | $2.8M | $2.1M | $2.3M | $9.4M | $1.0M | $704.9K | $1.6M | $1.6M | $3.1M | $5.8M | $658.3K | |||||||||||||||
| Comprehensive Income Net Of Tax | -$96.0M | -$97.1M | -$108.8M | -$67.8M | -$96.7M | -$115.4M | -$123.2M | -$106.1M | -$106.6M | -$99.0M | -$99.7M | -$93.3M | -$86.2M | -$81.4M | -$75.4M | -$58.7M | -$63.6M | -$68.9M | -$49.6M | -$47.3M | -$36.8M | -$33.9M | -$30.7M | -$26.5M | -$22.1M | -$23.4M | -$20.7M | -$18.7M | -$11.6M | -$6.9M | -$7.6M | -$6.3M | -$5.3M | -$2.8M | -$2.1M | ||||||||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $100.0K | -$30.0K | -$110.0K | $269.0K | $20.0K | -$69.0K | $18.0K | $118.0K | $776.0K | $659.0K | -$354.0K | -$1.7M | -$38.0K | -$63.0K | $77.0K | -$162.0K | -$595.0K | $692.0K | -$133.0K | $234.0K | $180.0K | -$117.0K | -$3.0K | $0.00 | $0.00 | -$2.0K | -$27.0K | $85.0K | $10.0K | $20.0K | $16.0K | $22.0K | $0.00 | ||||||||||||||||||
| General And Administrative Expense | $34.6M | $37.7M | $43.9M | $39.3M | $39.6M | $31.4M | $27.0M | $21.9M | $28.1M | $27.9M | $26.3M | $23.4M | $20.9M | $19.3M | $19.6M | $15.9M | $14.4M | $13.9M | $10.0M | $10.9M | $9.1M | $7.1M | $6.8M | $7.0M | $5.7M | $4.9M | $5.3M | $10.5M | $7.3M | $2.8M | $2.7M | $2.4M | $2.9M | ||||||||||||||||||
| Other Nonoperating Income Expense | $4.2K | $0.00 | $0.00 | -$2.4M | -$341.6K | $953.7K | $1.3M | -$2.6M | -$4.3K | $94.0K | |||||||||||||||||||||||||||||||||||||||||
| Interest Expense | -$4.2K | $0.00 | $0.00 | $104.1K | $341.6K | $126.9K | $110.8K | $88.5K | $31.6K | $0.00 | |||||||||||||||||||||||||||||||||||||||||
| Impairment Of Intangible Assets Excluding Goodwill | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||||||||||||||||||||||
| Cost Of Revenue | $38.5M | $56.7M | $49.7M | $31.5M | $31.4M | $7.3M | $4.3M | $2.1M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $698.6M | $710.4M | $584.6M | $499.6M | $621.7M | $656.5M | $299.0M | $466.2M | $145.5M | $166.9M | $104.0M | $44.8M | $17.6M | -$11.3M | -$12.8M | $638.1K | -$13.5K | $2.3K | $61.0K |
| Cash And Cash Equivalents At Carrying Value | $163.1M | $115.7M | $114.9M | $231.7M | $78.2M | $67.3M | $14.0M | $82.2M | $145.4M | $106.7M | $33.6M | $44.9M | $19.7M | $0.00 | $510.2K | $1.3M | $8.3K | $2.9K | $0.00 |
| Retained Earnings Accumulated Deficit | -$2.78B | -$2.38B | -$2.01B | -$1.57B | -$1.17B | -$830.2M | -$570.6M | -$249.2M | -$157.1M | -$104.2M | -$76.6M | -$64.5M | -$30.7M | -$27.4M | -$1.7M | ||||
| Property Plant And Equipment Net | $131.1M | $109.1M | $114.0M | $105.2M | $100.9M | $59.2M | $8.5M | $2.7M | $2.5M | $2.4M | $1.7M | $1.5M | $27.8K | $22.1K | $28.3K | $0.00 | |||
| Liabilities Current | $138.4M | $122.3M | $110.3M | $91.5M | $89.2M | $54.9M | $39.1M | $14.4M | $9.6M | $5.0M | $1.6M | $1.7M | $2.3M | $11.3M | $13.3M | $822.9K | |||
| Liabilities And Stockholders Equity | $913.2M | $910.4M | $780.4M | $664.0M | $777.3M | $768.5M | $344.7M | $480.8M | $155.4M | $171.9M | $105.7M | $46.5M | $19.9M | $29.4K | $568.4K | $1.5M | |||
| Assets Current | $442.7M | $457.0M | $307.8M | $479.1M | $508.0M | $636.1M | $316.5M | $475.4M | $149.3M | $169.5M | $104.0M | $45.0M | $19.8M | $7.3K | $524.1K | $1.3M | |||
| Assets | $913.2M | $910.4M | $780.4M | $664.0M | $777.3M | $768.5M | $344.7M | $480.8M | $155.4M | $171.9M | $105.7M | $46.5M | $19.9M | $29.4K | $568.4K | $1.5M | |||
| Accounts Payable Current | $22.2M | $27.5M | $33.1M | $26.6M | $27.4M | $13.5M | $15.6M | $2.7M | $1.2M | $863.0K | $958.0K | $1.2M | $413.0K | $1.1M | $190.0K | $30.3K | |||
| Common Stock Value | $17.0K | $13.0K | $11.0K | $8.0K | $7.0K | $5.0K | $5.0K | $3.0K | $3.0K | $2.0K | $2.0K | $835.00 | $34.00 | $3.3K | $3.1K | ||||
| Prepaid Expense And Other Assets Current | $11.6M | $12.4M | $17.5M | $7.3M | $3.5M | $6.7M | $9.4M | $6.9M | $3.9M | $3.0M | $277.0K | $66.0K | $173.7K | $5.0K | $9.4K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $169.1M | $122.1M | $181.3M | $238.2M | $84.3M | $72.9M | $19.4M | $82.2M | $145.4M | $106.7M | |||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$63.2M | $38.7M | $73.1M | -$11.3M | $25.2M | $19.7M | -$510.2K | -$782.3K | $1.3M | $5.4K | |||||||||
| Amortization Of Debt Discount Premium | $6.0M | $1.9M | -$3.4M | -$1.3M | $19.0K | -$74.0K | $0.00 | $0.00 | $497.9K | $5.0M | $0.00 | $0.00 | |||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $16.4M | -$1.0M | $2.5M | -$902.0K | -$601.0K | $19.0K | $220.0K | -$42.0K | $0.00 | $29.0K | $48.0K | $0.00 | |||||||
| Accretion Amortization Of Discounts And Premiums Investments | $7.2M | $10.3M | $3.6M | -$474.0K | -$6.0M | -$1.9M | $0.00 | -$497.9K | $5.0M | ||||||||||
| Accrued Liabilities Current | $52.3M | $56.8M | $35.1M | $16.3M | $11.7M | $8.4M | $4.1M | $672.0K | $328.0K | $1.5M | |||||||||
| Other Assets Noncurrent | $8.2M | $369.0K | $270.0K | $189.0K | $1.8M | $12.9M | $3.5M | $2.8M | $3.6M | $0.00 | |||||||||
| Liabilities Noncurrent | $76.2M | $77.7M | $85.4M | $72.9M | $66.5M | $57.1M | $6.6M | $230.0K | $297.0K | ||||||||||
| Liabilities | $214.6M | $200.0M | $195.7M | $164.3M | $155.7M | $112.0M | $45.7M | $14.6M | $9.9M | ||||||||||
| Operating Lease Right Of Use Asset | $45.9M | $55.2M | $62.5M | $73.0M | $69.0M | $54.8M | $10.7M | ||||||||||||
| Operating Lease Liability Noncurrent | $44.4M | $44.4M | $67.1M | $71.9M | $65.5M | $45.4M | $4.2M | ||||||||||||
| Operating Lease Liability Current | $4.0M | $12.9M | $7.8M | $12.6M | $5.1M | $6.3M | $7.3M | ||||||||||||
| Restricted Cash | $6.4M | $6.1M | $5.5M | $5.5M | |||||||||||||||
| Derivative Liability Recorded As Private Placement Cost | $0.00 | $697.4K | $642.3K | $0.00 | $0.00 | ||||||||||||||
| Short Term Investments | $133.9M | $208.1M | $165.0M | $240.1M | $426.2M | $562.1M | $293.1M | $386.4M | |||||||||||
| Debt Instrument Decrease Forgiveness | $0.00 | $0.00 | $0.00 | $18.1K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q1 2011 | Q3 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $702.3M | $698.5M | $767.9M | $773.5M | $768.5M | $680.0M | $674.0M | $578.6M | $666.9M | $393.7M | $472.7M | $552.0M | $698.3M | $744.4M | $647.4M | $711.8M | $758.3M | $243.3M | $355.1M | $397.4M | $434.9M | $254.2M | $270.6M | $292.6M | $165.4M | $129.2M | $149.9M | $179.1M | $188.9M | $98.9M | $109.4M | $112.9M | $111.6M | $16.2M | $17.4M | $16.8M | -$3.3M | -$2.8M | -$12.3M | -$16.6M | -$17.3M | |||||||
| Cash And Cash Equivalents At Carrying Value | $158.1M | $132.5M | $171.7M | $164.2M | $228.7M | $134.2M | $267.7M | $230.0M | $543.5M | $118.4M | $108.1M | $92.4M | $58.6M | $82.8M | $132.0M | $68.3M | $160.6M | $52.5M | $38.9M | $76.9M | $54.1M | $80.7M | $246.0M | $297.1M | $163.4M | $114.3M | $107.1M | $92.9M | $121.0M | $38.9M | $30.8M | $12.6M | $111.3M | $17.2M | $18.4M | $17.9M | $129.8K | $569.6K | $0.00 | $0.00 | $15.5K | $0.00 | $128.4K | $723.0K | $0.00 | |||
| Retained Earnings Accumulated Deficit | -$2.70B | -$2.61B | -$2.50B | -$2.31B | -$2.22B | -$2.13B | -$1.90B | -$1.78B | -$1.68B | -$1.46B | -$1.36B | -$1.26B | -$1.07B | -$987.0M | -$905.6M | -$761.8M | -$703.2M | -$640.2M | -$507.0M | -$457.6M | -$410.0M | $300.0K | -$340.2M | -$306.4M | -$275.7M | -$223.3M | -$201.2M | -$177.8M | -$141.4M | -$122.7M | -$111.1M | -$95.8M | -$88.2M | -$81.9M | -$71.7M | -$68.9M | -$66.8M | -$44.6M | -$35.2M | -$31.7M | -$34.2M | -$33.1M | ||||||
| Property Plant And Equipment Net | $126.7M | $122.5M | $111.6M | $112.5M | $111.0M | $111.8M | $113.1M | $112.5M | $109.9M | $100.7M | $101.2M | $102.8M | $88.0M | $80.1M | $72.8M | $39.1M | $18.7M | $13.6M | $5.9M | $4.5M | $3.5M | $2.6M | $2.7M | $2.2M | $2.6M | $2.6M | $2.8M | $1.8M | $1.2M | $1.4M | $1.8M | $2.0M | $2.1M | $171.0K | $15.8K | $14.6K | $29.9K | $19.0K | $20.2K | $23.7K | $26.8K | |||||||
| Liabilities Current | $125.8M | $129.2M | $122.7M | $118.1M | $93.6M | $83.2M | $91.0M | $88.6M | $87.3M | $79.2M | $64.2M | $77.1M | $64.8M | $60.5M | $55.1M | $64.4M | $54.9M | $39.5M | $34.6M | $33.8M | $22.1M | $16.7M | $14.2M | $14.7M | $8.5M | $8.9M | $5.5M | $3.2M | $4.6M | $1.8M | $2.9M | $1.9M | $1.9M | $1.3M | $1.2M | $1.1M | $3.5M | $3.4M | $12.3M | $16.6M | $17.3M | |||||||
| Liabilities And Stockholders Equity | $904.9M | $907.4M | $966.7M | $991.1M | $964.3M | $869.8M | $852.3M | $757.3M | $824.8M | $545.9M | $610.9M | $701.3M | $828.8M | $852.8M | $750.6M | $782.3M | $817.6M | $288.3M | $395.7M | $435.9M | $461.5M | $270.8M | $284.8M | $307.2M | $174.0M | $138.0M | $155.4M | $182.3M | $193.5M | $100.8M | $112.2M | $114.7M | $113.5M | $17.4M | $18.5M | $18.1M | $168.6K | $597.7K | $28.3K | $28.7K | $76.8K | |||||||
| Assets Current | $429.1M | $422.5M | $512.6M | $498.6M | $482.3M | $385.5M | $382.6M | $274.9M | $637.8M | $369.9M | $431.6M | $490.0M | $583.0M | $666.6M | $605.2M | $723.6M | $782.7M | $256.4M | $367.3M | $410.9M | $444.8M | $265.9M | $279.8M | $302.7M | $171.4M | $135.4M | $152.6M | $180.6M | $192.4M | $99.4M | $110.4M | $112.7M | $111.4M | $17.2M | $18.5M | $18.1M | $138.7K | $578.7K | $8.2K | $5.0K | $34.1K | |||||||
| Assets | $904.9M | $907.4M | $966.7M | $991.1M | $964.3M | $869.8M | $852.3M | $757.3M | $824.8M | $545.9M | $610.9M | $701.3M | $828.8M | $852.8M | $750.6M | $782.3M | $817.6M | $288.3M | $395.7M | $435.9M | $461.5M | $270.8M | $284.8M | $307.2M | $174.0M | $138.0M | $155.4M | $182.3M | $193.5M | $100.8M | $112.2M | $114.7M | $113.5M | $17.4M | $18.5M | $18.1M | $168.6K | $597.7K | $28.3K | $28.7K | $76.8K | |||||||
| Accounts Payable Current | $31.2M | $32.0M | $28.5M | $31.7M | $20.4M | $25.7M | $19.3M | $31.2M | $31.6M | $24.3M | $20.0M | $20.5M | $12.2M | $21.9M | $13.4M | $24.8M | $10.2M | $10.6M | $9.9M | $12.8M | $7.6M | $6.0M | $5.2M | $6.6M | $2.9M | $3.7M | $2.2M | $228.0K | $725.0K | $1.1M | $1.2M | $1.2M | $1.1M | $573.8K | $440.6K | $286.3K | $1.6M | $1.5M | $1.3M | $841.6K | $504.3K | |||||||
| Common Stock Value | $16.0K | $14.0K | $14.0K | $13.0K | $12.0K | $12.0K | $11.0K | $9.0K | $9.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $1.9K | $1.2K | $1.1K | $921.00 | $629.00 | $556.00 | $34.00 | $3.3K | $3.3K | ||||||
| Prepaid Expense And Other Assets Current | $9.8M | $11.5M | $15.9M | $6.7M | $10.2M | $11.5M | $12.0M | $14.2M | $11.5M | $9.7M | $7.1M | $7.8M | $6.6M | $10.3M | $11.3M | $9.4M | $10.8M | $10.7M | $5.4M | $6.8M | $4.7M | $5.9M | $3.7M | $5.6M | $8.0M | $6.4M | $5.4M | $1.3M | $782.0K | $193.0K | $245.0K | $378.4K | $128.9K | $15.1K | $9.7K | $10.0K | $5.0K | $5.0K | $5.0K | $5.0K | $34.1K | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $164.1M | $138.4M | $178.0M | $170.5M | $235.1M | $140.6M | $334.2M | $296.4M | $549.9M | $124.8M | $114.5M | $98.4M | $64.7M | $88.8M | $138.0M | $73.8M | $166.1M | $58.1M | $44.3M | $82.4M | $54.1M | $80.7M | $246.0M | |||||||||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$28.1M | $151.7M | $382.0K | $5.3M | $66.4M | -$1.7M | $0.00 | -$510.2K | -$569.5K | |||||||||||||||||||||||||||||||||||||||
| Amortization Of Debt Discount Premium | $2.1M | -$50.0K | -$1.2M | $0.00 | $28.0K | $0.00 | $0.00 | $0.00 | $497.9K | $0.00 | $2.6M | $0.00 | ||||||||||||||||||||||||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $16.1M | $20.9M | $6.3M | $16.2M | $526.0K | $116.0K | -$9.1M | $325.0K | -$126.0K | -$2.0M | -$2.7M | -$2.3M | -$5.0K | $33.0K | $96.0K | $155.0K | $317.0K | $912.0K | $861.9M | $854.6M | $138.0K | -$120.0K | -$3.0K | $0.00 | $0.00 | $2.0K | $163.0K | $78.0K | $68.0K | $38.0K | $21.7K | |||||||||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $2.1M | $2.3M | $978.0K | -$541.0K | -$2.1M | $0.00 | $0.00 | |||||||||||||||||||||||||||||||||||||||||
| Accrued Liabilities Current | $74.8M | $61.8M | $46.4M | $69.4M | $61.2M | $46.6M | $43.1M | $47.8M | $37.7M | $48.9M | $46.0M | $34.2M | $35.8M | $32.4M | $38.8M | $22.5M | $16.3M | $13.6M | $8.5M | $10.7M | $9.0M | $8.1M | $5.6M | $5.2M | $3.3M | $3.0M | $3.9M | $690.0K | $1.6M | $623.8K | $717.8K | |||||||||||||||||
| Other Assets Noncurrent | $9.3M | $10.3M | $426.0K | $280.0K | $327.0K | $259.0K | $282.0K | $294.0K | $202.0K | $596.0K | $856.0K | $1.3M | $1.0M | $1.2M | $1.2M | $3.4M | $3.2M | $3.5M | $3.4M | $3.3M | $3.3M | $2.3M | $2.3M | $2.3M | ||||||||||||||||||||||||
| Liabilities Noncurrent | $76.9M | $79.8M | $76.2M | $99.6M | $102.1M | $106.6M | $87.4M | $90.1M | $70.6M | $72.9M | $74.0M | $72.2M | $65.7M | $47.8M | $48.1M | $6.1M | $4.4M | $5.4M | $6.1M | $4.7M | $4.4M | |||||||||||||||||||||||||||
| Liabilities | $202.7M | $208.9M | $198.9M | $217.7M | $195.8M | $189.8M | $178.3M | $178.7M | $157.9M | $152.2M | $138.2M | $149.3M | $130.5M | $108.4M | $103.1M | $70.5M | $59.3M | $45.0M | $40.7M | $38.5M | $26.6M | |||||||||||||||||||||||||||
| Operating Lease Right Of Use Asset | $48.8M | $49.9M | $50.9M | $66.7M | $69.1M | $71.5M | $66.3M | $67.6M | $70.4M | $68.3M | $70.8M | $73.5M | $72.4M | $52.5M | $55.1M | $10.7M | $7.5M | $9.3M | $13.7M | $11.7M | $10.0M | $10.4M | ||||||||||||||||||||||||||
| Operating Lease Liability Noncurrent | $45.2M | $45.1M | $44.2M | $66.4M | $69.2M | $72.3M | $68.0M | $68.8M | $69.6M | $71.9M | $73.0M | $71.2M | $64.7M | $46.8M | $47.1M | $3.7M | $2.0M | $3.1M | $6.0M | $4.6M | $4.4M | $5.8M | ||||||||||||||||||||||||||
| Operating Lease Liability Current | $6.3M | $7.1M | $8.5M | $11.6M | $11.4M | $11.1M | $10.5M | $10.9M | $12.6M | $7.2M | $6.5M | $7.7M | $6.6M | $4.4M | $5.9M | $7.2M | $5.9M | $6.4M | $8.4M | $7.5M | $6.1M | $4.9M | ||||||||||||||||||||||||||
| Restricted Cash | $6.4M | $66.4M | $66.4M | $66.4M | $6.4M | $6.4M | $6.4M | $6.1M | $6.1M | $6.1M | $6.1M | $5.5M | $5.5M | $5.5M | $5.5M | $5.5M | ||||||||||||||||||||||||||||||||
| Derivative Liability Recorded As Private Placement Cost | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||||||||||||||||||||
| Short Term Investments | $142.7M | $168.7M | $188.0M | $233.3M | $183.9M | $222.0M | $93.7M | $20.9M | $82.8M | $241.8M | $316.4M | $389.8M | $517.9M | $573.6M | $472.2M | $645.8M | $611.3M | $193.1M | ||||||||||||||||||||||||||||||
| Debt Instrument Decrease Forgiveness | $0.00 | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $300.8M | $390.7M | $463.0M | $190.2M | $239.3M | $576.4M | $6.1M | $424.3M | $58.7M | $96.9M | $78.3M | $35.5M | $23.3M | $1.7M | $5.5M | $1.9M | $19.8K |
| Investing Cash Flow * | $47.5M | -$96.4M | -$155.2M | $256.5M | $132.0K | -$317.9M | $90.0M | -$386.3M | $58.7M | $8.9M | -$71.2M | -$1.6M | -$12.7K | $0.00 | -$81.1K | $0.00 | $0.00 |
| Operating Cash Flow * | -$302.4M | -$353.0M | -$361.8M | -$292.8M | -$227.9M | -$205.1M | -$158.9M | -$101.2M | -$78.7M | -$32.7M | -$18.4M | -$8.6M | -$3.7M | -$2.2M | -$6.2M | -$620.8K | -$14.4K |
| Share Based Compensation | $61.6M | $109.6M | $62.6M | $84.0M | $69.8M | $40.9M | $24.3M | $20.0M | $12.0M | $18.9M | $8.5M | $3.8M | $2.8M | $2.5M | $14.6M | $114.0K | $0.00 |
| Proceeds From Issuance Of Common Stock | $306.3M | $397.3M | $463.3M | $189.5M | $203.2M | $567.0M | $398.8M | $53.7M | $95.7M | $68.3M | $32.2M | $7.1M | $250.0K | $873.0K | $1.9M | $0.00 | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $8.0M | $2.1M | $10.1M | $2.1M | -$2.8M | $6.7M | $3.3M | $2.1M | $4.5M | $2.8M | $211.0K | -$108.0K | $164.0K | -$22.6K | -$21.4K | ||
| Payments To Acquire Property Plant And Equipment | $33.8M | $11.1M | $22.3M | $20.4M | $37.6M | $46.8M | $6.9M | $1.2M | $1.0M | $1.5M | $1.1M | $1.6M | $13.0K | $0.00 | $31.1K | $0.00 | $0.00 |
| Increase Decrease In Accrued Liabilities | $28.6M | $8.6M | $19.8M | -$4.7M | $20.7M | $24.1M | $6.7M | $3.2M | $4.6M | $3.4M | $258.0K | -$608.0K | $1.7M | $70.0K | |||
| Proceeds From Sale And Maturity Of Available For Sale Securities | $400.0M | $428.0M | $285.6M | $522.7M | $762.9M | $676.6M | $514.6M | $41.0M | $59.7M | $120.7M | $70.6M | $0.00 | $0.00 | ||||
| Increase Decrease In Accounts Payable | -$6.7M | -$7.8M | $4.8M | $5.9M | $7.0M | -$3.0M | $12.7M | $1.5M | $369.0K | -$250.0K | -$290.0K | $908.2K | $159.8K | ||||
| Proceeds From Stock Options Exercised | $15.0K | $3.3M | $63.0K | $1.6M | $33.5M | $9.7M | $6.4M | $10.0M | $5.6M | $626.0K | $255.0K | $0.00 | $0.00 | ||||
| Payments Related To Tax Withholding For Share Based Compensation | $7.1M | $12.9M | $2.8M | $2.6M | $284.0K | $312.0K | $223.0K | $1.3M | $642.0K | $0.00 | $0.00 | ||||||
| Depreciation Depletion And Amortization | $12.9M | $11.3M | $11.6M | $9.3M | $3.1M | $1.1M | $1.2M | $956.0K | $952.0K | ||||||||
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | -$32.0K | -$608.0K | -$98.0K | $1.9M | |||||||||||||
| Proceeds From Convertible Debt | $0.00 | $0.00 | $311.0K | $0.00 | $4.6M | $0.00 | $0.00 | ||||||||||
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | $104.0K | $16.0K | $8.9K | $2.7K | $0.00 | ||||||||||||
| Payments To Acquire Available For Sale Securities Debt | $318.7M | $460.8M | $205.9M | $245.8M | $725.2M | $947.7M | $417.7M | $426.1M | |||||||||
| Proceeds From Warrant Exercises | $15.8M | $662.0K | $1.2M | $9.7M | $3.2M | $0.00 | |||||||||||
| Payments To Acquire Available For Sale Securities | $417.7M | $426.1M | $0.00 | $110.2M | $140.7M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q1 2021 | Q2 2020 | Q1 2020 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q1 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $143.3M | $193.6M | $258.2M | $1.4M | $50.4M | $3.8M | -$2.0K | $169.6M | $383.0K | $0.00 | $70.6M | $542.5K | $300.0K | $250.0K | $45.0K | |||||||||||||||||||||||||
| Investing Cash Flow * | $15.9M | -$111.5M | $153.4M | $86.5M | $77.2M | $100.1M | $1.0M | -$22.0K | $18.8M | $9.9M | -$782.0K | -$3.4K | $0.00 | $0.00 | -$50.0K | |||||||||||||||||||||||||
| Operating Cash Flow * | -$103.7M | -$122.3M | -$99.8M | -$73.8M | -$62.4M | -$65.3M | -$29.1M | -$17.8M | -$18.8M | -$4.6M | -$3.5M | -$2.3M | -$300.0K | -$760.2K | -$564.5K | |||||||||||||||||||||||||
| Share Based Compensation | $11.9M | $22.9M | $31.0M | $17.2M | $15.7M | $22.3M | $16.9M | $9.4M | $5.8M | $5.4M | $5.2M | $4.1M | $2.6M | $3.0M | $3.3M | $7.9M | $4.6M | $1.8M | $1.5M | $939.3K | $919.4K | $919.4K | $2.1M | $87.4K | $87.4K | $697.7K | $469.5K | $1.2M | $532.5K | $40.3K | ||||||||||
| Proceeds From Issuance Of Common Stock | $148.9M | $197.9M | $260.1M | $0.00 | $42.9M | $567.0M | $0.00 | $162.2M | $0.00 | $0.00 | $68.3M | $0.00 | $250.0K | $45.0K | ||||||||||||||||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $3.3M | -$5.9M | $4.2M | $3.7M | $4.1M | $1.3M | -$1.6M | $368.0K | $2.4M | -$84.0K | $62.0K | -$49.6K | -$875.00 | -$20.2K | $6.8K | |||||||||||||||||||||||||
| Payments To Acquire Property Plant And Equipment | $6.2M | $4.2M | $5.7M | $11.4M | $10.7M | $637.0K | $824.0K | $22.0K | $798.0K | $2.0K | $782.0K | $3.4K | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||
| Increase Decrease In Accrued Liabilities | $2.3M | -$23.0M | -$9.1M | -$5.2M | -$3.3M | $4.4M | -$3.3M | -$546.0K | -$776.0K | $104.0K | $866.0K | |||||||||||||||||||||||||||||
| Proceeds From Sale And Maturity Of Available For Sale Securities | $120.0M | $87.0M | $164.4M | $143.5M | $158.3M | $113.7M | $91.0M | $0.00 | $19.6M | $39.2M | $0.00 | |||||||||||||||||||||||||||||
| Increase Decrease In Accounts Payable | $2.1M | -$5.8M | $3.0M | -$2.1M | -$15.0K | -$7.8M | $4.6M | $5.2M | $1.5M | $96.0K | ||||||||||||||||||||||||||||||
| Proceeds From Stock Options Exercised | $15.0K | $364.0K | $0.00 | $1.4M | $6.5M | $4.0M | $69.0K | $5.6M | $231.0K | $0.00 | ||||||||||||||||||||||||||||||
| Payments Related To Tax Withholding For Share Based Compensation | $5.6M | $4.7M | $1.9M | $0.00 | $118.0K | $71.0K | $62.0K | $4.0K | $0.00 | |||||||||||||||||||||||||||||||
| Depreciation Depletion And Amortization | $3.4M | $2.8M | $3.0M | $3.0M | $3.0M | $2.9M | $2.9M | $2.8M | $2.5M | $2.2M | $1.8M | $372.0K | $252.0K | $271.0K | ||||||||||||||||||||||||||
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | $200.0K | $249.0K | -$993.4K | $316.4K | $372.2K | $0.00 | ||||||||||||||||||||||||||||||||||
| Proceeds From Convertible Debt | $300.0K | $0.00 | $0.00 | |||||||||||||||||||||||||||||||||||||
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | $1.6K | $1.4M | $1.1K | $794.0K | $529.9K | $289.7K | $38.8K | $33.7K | $32.6K | $13.8K | $12.0K | $10.9K | $7.4K | $4.3K | ||||||||||||||||||||||||||
| Payments To Acquire Available For Sale Securities Debt | $97.9M | $141.8M | $5.3M | $45.6M | $70.4M | $12.9M | ||||||||||||||||||||||||||||||||||
| Proceeds From Warrant Exercises | $0.00 | $1.8M | $156.0K | $0.00 | $2.3M | |||||||||||||||||||||||||||||||||||
| Payments To Acquire Available For Sale Securities | $12.9M | $89.2M | $0.00 | $0.00 | $29.3M | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.09 | -$1.28 | -$1.89 | -$2.49 | -$2.23 | -$1.88 | -$1.59 | -$1.27 | -$1.41 | -$1.85 | -$0.62 | -$0.48 | -$3.47 | -$4.14 | -$0.34 | -$0.02 | $0.00 |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 138.3K | 124.3K | 97.3K | 65.2K | 55.3K | 44.4K | 25.0K | 9.8M | 798.5K | 75.9M | |||||||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 300.0M | 300.0M | 300.0M | 300.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 1.80B | 1.80B | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 411.9M | 305.3M | 256.1M | 187.8M | 157.0M | 147.9M | 126.4M | 123.4M | 73.2M | 62.2M | 48.5M | 33.8M | 20.0M | 818.8K | 78.0M | 73.6M | |
| Common Stock Shares Issued | 411.9M | 305.3M | 256.1M | 187.8M | 157.0M | 146.9M | 126.4M | 123.4M | 73.2M | 62.2M | 48.5M | 33.8M | 20.0M | 818.8K | 78.0M | 73.6M | |
| Earnings Per Share Basic | $-1.09 | $-1.28 | $-1.89 | $-2.49 | $-2.23 | $-1.88 | $-1.59 | ||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 357.3K | 289.9K | 235.1K | 159.3K | 153.4K | 138.3K | 124.3K | ||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 357.3K | 289.9K | 235.1K | 159.3K | 153.4K | 138.3K | 124.3K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q1 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.33 | -$0.36 | -$0.28 | -$0.34 | -$0.42 | -$0.46 | -$0.47 | -$0.50 | -$0.63 | -$0.63 | -$0.58 | -$0.55 | -$0.53 | -$0.51 | -$0.47 | -$0.40 | -$0.47 | -$0.55 | -$0.50 | -$0.40 | -$0.38 | -$0.30 | -$0.27 | -$0.36 | -$0.34 | -$0.31 | -$0.36 | -$0.35 | -$0.37 | -$0.33 | -$0.25 | -$1.15 | -$0.23 | -$0.14 | -$0.17 | -$0.16 | -$0.14 | -$0.14 | -$0.17 | -$0.11 | -$0.09 | -$0.11 | -$0.66 | -$4.19 | -$1.28 | -$0.86 | $0.00 | $7.39 | -$0.07 | -$0.01 | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 153.8K | 147.4K | 146.7K | 146.5K | 133.2K | 126.6K | 126.3K | 124.0K | 123.6K | 123.4K | 119.1K | 95.1K | 90.2K | 84.4K | 72.8K | 63.3K | 62.5K | 62.3K | 62.1K | 59.1K | 51.1K | 48.5K | 47.9K | 47.3K | 45.1K | 37.7K | 28.3K | 26.6K | 24.1K | 20.8K | 14.2M | 818.8K | 818.8K | 782.9K | 782.9K | 781.4K | 78.3M | ||||||||||||||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 18.0M | 18.0M | 1.80B | 1.80B | |||||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||
| Common Stock Shares Outstanding | 385.5M | 341.9M | 333.9M | 304.6M | 297.3M | 279.8M | 255.8M | 224.7M | 224.4M | 157.8M | 157.8M | 157.2M | 156.7M | 154.8M | 149.3M | 146.6M | 146.4M | 126.8M | 126.2M | 123.8M | 123.4M | 97.4M | 92.7M | 89.6M | 72.0M | 62.7M | 62.4M | 61.9M | 58.4M | 48.5M | 47.8M | 47.1M | 44.9M | 27.6M | 27.2M | 22.1M | 15.1M | 13.3M | 818.8K | 78.3M | 78.3M | ||||||||||
| Common Stock Shares Issued | 385.5M | 341.9M | 333.9M | 304.6M | 297.3M | 279.8M | 255.8M | 224.7M | 224.4M | 157.8M | 157.8M | 157.2M | 156.7M | 154.8M | 149.3M | 146.6M | 146.4M | 126.8M | 126.2M | 123.8M | 123.4M | 97.4M | 92.7M | 89.6M | 72.0M | 62.7M | 62.4M | 61.9M | 58.4M | 48.5M | 47.8M | 47.1M | 44.9M | 27.6M | 27.2M | 22.1M | 15.1M | 13.3M | 818.8K | 78.3M | 78.3M | ||||||||||
| Earnings Per Share Basic | $-0.25 | $-0.33 | $-0.36 | $-0.28 | $-0.34 | $-0.42 | $-0.46 | $-0.47 | $-0.50 | $-0.63 | $-0.63 | $-0.58 | $-0.55 | $-0.53 | $-0.51 | $-0.40 | $-0.47 | ||||||||||||||||||||||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 364.0K | 334.5K | 322.9K | 303.3K | 284.8K | 266.2K | 245.8K | 224.5K | 213.7M | 157.8M | 157.3M | 157.1M | 155.5M | 153.8M | 147.4K | 146.5K | |||||||||||||||||||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 334.5K | 322.9K | 303.3K | 284.8K | 266.2K | 245.8K | 224.5K | 213.7M | 157.8M | 157.3M | 157.1M | 155.5M | 153.8M | 147.4K | 146.5K |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $10.3M | $20.3M | $13.0M | $3.0M | $451.0K | $2.4M | $9.3M | $4.7M | $813.0K | $745.0K | $200.0K | $6.0K | |||||
| Depreciation And Amortization | $35.9M | $37.6M | $21.4M | $956.0K | $952.0K | $978.0K | $999.0K | $88.0K | $7.0K | $6.2K | $2.7K | $58.6K | $1.3K | ||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $60.9M | $110.9M | $62.6M | $84.0M | $69.8M | $40.8M | $24.3M | $20.0M | $12.0M | $18.9M | $6.8M | $2.6M | |||||
| Operating Costs And Expenses | $9.3M | $4.7M | $6.5M | $19.3M | $643.9K | $15.8K | |||||||||||
| Stock Issued During Period Value Stock Options Exercised | $15.0K | $3.3M | $63.0K | $1.6M | $33.5M | $9.7M | $6.4M | $10.0M | $5.6M | $626.0K | $255.0K | ||||||
| Additional Paid In Capital | $3.46B | $3.10B | $2.59B | $2.07B | $1.79B | $1.49B | $869.4M | $839.0M | $394.7M | $324.0M | $208.2M | $121.2M | $81.9M | ||||
| Stock Option Plan Expense | $6.8M | $2.6M | $747.0K | $2.5M | $1.8M | $114.0K | $0.00 | ||||||||||
| Issuance Of Stock And Warrants For Services Or Claims | $1.8M | $1.3M | $274.0K | $800.0K | $498.5K | $0.00 | $0.00 | ||||||||||
| Stock Issued During Period Value New Issues | $463.3M | $189.5M | $203.2M | $567.0M | $398.8M | $53.7M | $68.3M | ||||||||||
| Derivative Gain Loss On Derivative Net | $0.00 | $8.6M | -$1.6M | ||||||||||||||
| Stock Issued During Period Value Other | $306.3M | $397.3M | $463.3M | $189.5M | $203.2M | $44.0M | $32.2M | $5.9M | $67.9K | $1.9M | |||||||
| Stock Issued1 | $0.00 | $0.00 | -$2.0M | $0.00 | $0.00 | $217.4K | $0.00 | ||||||||||
| Conversion Of Stock Amount Converted1 | $1.0K | $1.0K | $2.0K | $1.0K | $1.0K | $3.0K | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q1 2011 | Q4 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $1.2M | $4.1M | $3.2M | $4.0M | $3.4M | $3.3M | $3.4M | $3.1M | $3.5M | $777.0K | $385.0K | $106.0K | $120.0K | $75.0K | $121.0K | $395.0K | $609.0K | $1.2M | $2.1M | $2.6M | $3.0M | $1.2M | $718.0K | $362.0K | $194.0K | $204.0K | $198.0K | $221.0K | $164.0K | $126.0K | $8.0K | $72.7K | $5.0K | ||||||||||||
| Depreciation And Amortization | $9.0M | $9.7M | $271.0K | $228.0K | $221.0K | $269.0K | $185.0K | $16.6K | $2.0K | $1.6K | $18.1K | ||||||||||||||||||||||||||||||||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $11.8M | $14.5M | $23.0M | $30.8M | $31.8M | $17.8M | $15.8M | $16.7M | $15.7M | $19.8M | $22.5M | $22.3M | $19.3M | $14.4M | $16.9M | $10.7M | $10.5M | $9.4M | $6.6M | $6.4M | $5.8M | $5.5M | $5.2M | $4.1M | |||||||||||||||||||||
| Operating Costs And Expenses | $2.7M | $2.4M | $3.3M | $2.4M | $1.6M | $2.0M | $2.5M | $779.3K | $434.9K | $1.4M | $1.4M | $2.3M | $5.8M | $658.3K | |||||||||||||||||||||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $15.0K | $713.0K | $390.0K | $364.0K | $55.0K | $225.0K | $1.4M | $20.8M | $2.7M | $6.5M | $1.5M | $1.2M | $4.0M | $762.0K | $3.4M | $69.0K | $1.5M | $1.2M | $5.6M | ||||||||||||||||||||||||||
| Additional Paid In Capital | $3.39B | $3.29B | $3.26B | $3.06B | $2.99B | $2.81B | $2.58B | $2.36B | $2.34B | $1.86B | $1.84B | $1.82B | $1.77B | $1.73B | $1.55B | $1.47B | $1.46B | $882.6M | $239.0K | $372.0K | $844.8M | $594.5M | $576.9M | $568.2M | $388.8M | $330.3M | $327.7M | $320.1M | $311.3M | $209.7M | $204.9M | $200.8M | $193.2M | ||||||||||||
| Stock Option Plan Expense | $1.5M | $1.0M | $901.7K | $87.4K | $1.2M | $40.3K | |||||||||||||||||||||||||||||||||||||||
| Issuance Of Stock And Warrants For Services Or Claims | $296.0K | $450.0K | $17.7K | $0.00 | $50.0K | $0.00 | |||||||||||||||||||||||||||||||||||||||
| Stock Issued During Period Value New Issues | $88.5M | $13.1M | $148.9M | $47.5M | $152.4M | $197.4M | $203.2M | $260.1M | $160.3M | $42.9M | $43.0K | $567.0M | $162.1M | $67.9K | $8.0K | ||||||||||||||||||||||||||||||
| Derivative Gain Loss On Derivative Net | $0.00 | $2.5M | $94.0K | ||||||||||||||||||||||||||||||||||||||||||
| Stock Issued During Period Value Other | $152.4M | $197.4M | $203.2M | $260.1M | $68.3M | $53.0K | |||||||||||||||||||||||||||||||||||||||
| Stock Issued1 | $0.00 | $0.00 | $217.4K | ||||||||||||||||||||||||||||||||||||||||||
| Conversion Of Stock Amount Converted1 | $1.0K | $0.00 | $0.00 | $1.0K |
Most recent annual filing with the SEC: February 24, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.